DRO320
Monografia
4384
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA
Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs / European Monitoring Centre for Drugs and Drug Addiction.- Luxembourg : Office for Official Publications of the European Communities, 2002.- 116 p. ; il. ; 21 cm. - (Implemention of the joint action ; 3)
Informação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: http://www.emcdda.org
ISBN 92-9168-123-7 (Broch.) : oferta
DROGA, DROGAS ILICITAS, SUBSTÂNCIAS PSICOTRÓPICAS, COOPERAÇÃO INTERNACIONAL, SAÚDE PÚBLICA, MEDICINA, RELATÓRIO, ESTATISTICAS, EUROPOL, CONSELHO DA EUROPA
Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on ketamine in accordance with Article 3 of the joint action of 16 june 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of ketamine in human medicine in the EU Member States. Use of ketamine in veterinary medicine in the EU Member States. Review of the pharmacotoxicological data on ketamine. Sociological and criminological (Europol) evidence. Public health risks - epidemiological evidence.